Literature collection
A structured collection of microbiome-related scientific literature, with one claim per study. Entries are not filtered by certainty or consensus, the point is traceability, not authority.
Collection entries
human mouse mixed
| Paper | One-sentence claim | Study type | Limitation | Tags | |
|---|---|---|---|---|---|
| H | Arumugam et al., 2011, Nature | gut-microbiome, enterotypes, bacteroides, prevotella, ruminococcus | |||
| ? | Belzer et al., 2017, mBio | Akkermansia muciniphila cross-feeds mucin-derived substrates to butyrate producers including Faecalibacterium prausnitzii, the taxa can coexist and support each other ecologically rather than acting as simple opposites. | Co-culture mechanistic study | In vitro co-cultures; relative abundance on consumer reports does not prove cross-feeding activity in vivo | akkermansia, faecalibacterium, cross-feeding, butyrate, synthesis |
| H | Black et al., 2022, Gut | Network meta-analysis of IBS dietary RCTs ranked low-FODMAP first for global symptom improvement and abdominal bloating/distension vs habitual and several comparator diets. | Network meta-analysis | Mostly short trials; dietitian delivery varies; long-term data limited | bloating, fodmap, ibs, meta-analysis, diet |
| H | Bulygin et al., 2021, bioRxiv | gut-microbiome, enterotypes, dimensionality-reduction, clustering, 16s-rrna, metagenomics, american-gut-project, human-microbiome-project | |||
| H | Bulygin et al., 2023, PeerJ | Enterotype classifications, such as those reported by consumer gut microbiome tests, are likely artificial labels imposed on what is actually a smooth, continuous spectrum of variation; no matter what your test says, your gut microbiome probably doesn't neatly belong to one distinct biological 'type'. | Computational reanalysis (human metagenomics) | This study only addresses whether gut microbiome 'types' are real as discrete categories, it does not mean that the ratio of certain gut bacteria (like Prevotella vs Bacteroides) is useless. Those ratios may still turn out to be meaningful markers for health and diet, even if the hard boundaries between 'types' are not. | gut-microbiome, enterotypes, dimensionality-reduction, clustering, 16s-rrna, metagenomics, american-gut-project, human-microbiome-project |
| H | Camilleri et al., 2023, Am J Gastroenterol (ACG constipation guideline) | ACG guidance on chronic idiopathic constipation recommends pathophysiology-based evaluation (transit vs outlet dysfunction) and evidence-supported fibre, osmotic laxatives, and pelvic floor biofeedback rather than unvalidated testing alone. | Guideline | Guideline synthesis; access to manometry and transit tests varies | constipation, motility, guidelines, pelvic-floor |
| + | Cani et al., 2007, Diabetes | High-fat feeding raises plasma LPS in mice and humans; metabolic endotoxemia via TLR4 signalling links gut barrier permeability to obesity and insulin resistance in models. | Mechanistic human + mouse | Rodent diets and acute human meal challenges; causality in free-living humans incomplete | lps, endotoxemia, metabolic, obesity, barrier |
| H | Costea et al., 2018, Nature Microbiology | gut-microbiome, enterotypes, gradients, clustering | |||
| H | Depommier et al., 2017, Nature Medicine | Pasteurized A. muciniphila supplementation improved insulin sensitivity in overweight adults. | RCT (human) | Small sample; specific preparation and dose; not a consumer stool test endpoint | akkermansia, intervention, metabolism |
| H | Duvallet et al., 2017, Nature Communications verified | Re-analysis of 28 case–control 16S studies shows most disease-associated microbiome shifts are shared across conditions, not disease-specific. Alpha diversity falls reliably in diarrhoea and perhaps IBD, but not in obesity or most other diseases. Enrichment of a few pathogens (e.g. CRC) contrasts with depletion of health-associated Clostridiales in IBD; ~51% of genus associations recur in more than one disease. | Meta-analysis | 16S amplicon studies only; disease heterogeneity within categories; antibiotic use and symptom overlap (e.g. diarrhoea) confound many associations; genus-level resolution cannot resolve strain-level pathogenic vs commensal roles | alpha-diversity, meta-analysis, dysbiosis, ibd, crc, diarrhea, confounding, methodology, interpretation |
| M | Everard et al., 2013, PNAS | Obese mice had lower A. muciniphila abundance, and restoring it improved metabolic markers. | Preclinical (mouse) | Animal model; not direct evidence for human test interpretation | akkermansia, obesity, metabolism |
| H | Ford et al., 2019, Gut (probiotics for IBS network meta-analysis) | Network meta-analysis of probiotics in IBS shows benefit for some endpoints but substantial heterogeneity between strains, no single probiotic class effect. | Meta-analysis | Trial quality varies; strain formulations differ from consumer products | probiotics, ibs, meta-analysis |
| H | Franzosa et al., 2019, Cell Host & Microbe | Longitudinal metagenomics in adults shows person-specific microbiome signatures that persist over time, supporting individualized baselines rather than one universal healthy template for dysbiosis scoring. | Longitudinal cohort | Relative abundance focus; functional measures add complementary signal | dysbiosis, personalization, longitudinal, interpretation |
| H | Halmos et al., 2014, Gastroenterology | Crossover trial in IBS: a low-FODMAP diet reduced overall GI symptoms, bloating, pain, and wind vs a typical Australian diet; controls were unaffected. | Randomized crossover feeding trial | Short-term controlled diet; not all real-world FODMAP trials match design | bloating, fodmap, ibs, fermentation, hydrogen |
| H | Hill et al., 2014, Nat Rev Gastroenterol Hepatol (ISAPP probiotics) | ISAPP consensus defines probiotics as live microorganisms conferring health benefits at adequate doses and stresses that benefits are strain-specific, not genus-level. | Guideline | Consensus definition; does not rate individual commercial products | probiotics, isapp, bifidobacterium, lactobacillus |
| H | Hooks & O'Malley, 2017, mBio | Commentary arguing that "dysbiosis" is an imprecise ecological descriptor, not a standalone diagnosis, and that microbiome studies need clearer mechanistic hypotheses than deviation from a reference community. | Review | Commentary; does not define vendor scoring algorithms | dysbiosis, interpretation, methodology |
| H | Human Microbiome Project Consortium, 2012, Nature | Healthy human gut microbiomes are highly variable between individuals but stable within individuals over time. | Observational cohort | 2012 sequencing depth and methods; limited diversity sampling | diversity, baseline, methodology |
| H | Imhann et al., 2016, Science | Population cohort links many non-antibiotic drugs, including PPIs, metformin, and laxatives, to characteristic shifts in gut microbiome composition. | Observational cohort | Association not causation; medication indication confounds | medications, ppi, metformin, drug-microbiome |
| H | Jeffery et al., 2012, Nature Reviews Microbiology | The neat division of gut microbiomes into distinct enterotypes may be an oversimplification, the data more likely reflects a continuous gradient running from Bacteroides-dominated to Prevotella-dominated communities, with no clean boundaries in between. | Expert commentary / narrative review | This paper questions the discreteness of enterotypes but does not itself provide new experimental data, it is a conceptual reappraisal of existing studies, and the authors acknowledge that linking microbiome composition patterns to clinical outcomes remains a worthwhile and open goal, regardless of whether those patterns are gradients or clusters. | gut-microbiome, enterotypes, bacteroides, prevotella, ruminococcus, microbiome-gradients, 16s-rrna, diet, ageing, co-abundance-groups |
| M | Johansson et al., 2011, PNAS | Colon mucus is organized into inner and outer MUC2 layers; the inner layer is largely bacteria-free in health and forms a critical physical barrier. | Observational | Mouse model; human mucus architecture broadly similar but not identical | mucus, muc2, intestinal-barrier, colon |
| H | Knights et al., 2014, Cell Host & Microbe | gut-microbiome, enterotypes, clustering, longitudinal, methodology | |||
| H | Lacy et al., 2021, Am J Gastroenterol (ACG IBS guideline) | ACG guidance on IBS management emphasises identifying alarm features, selective diagnostic testing, and evidence-based dietary and pharmacologic options rather than unvalidated microbiome-based protocols. | Guideline | Guideline synthesis; individual patient workup varies by health system | ibs, red-flags, clinical-care, guidelines |
| + | Langille et al., 2013, Nature Biotechnology | Metagenomic gene content can predict microbial community metabolic profiles using reference genome databases, supporting pathway inference while highlighting database completeness limits. | Methods / validation | Reference-genome-dependent; human stool validation subset only | metagenomics, pathways, functional-profiling, prediction |
| H | Lopez-Siles et al., 2018, Front Cell Infect Microbiol | Akkermansia muciniphila and Faecalibacterium prausnitzii co-occur in mucosal microbiota; both can be altered in IBD but are not mutually exclusive markers of health vs disease in individuals. | Observational (mucosal biopsies) | IBD cohort; stool reports may not reflect mucosal co-occurrence | akkermansia, faecalibacterium, ibd, co-occurrence, synthesis |
| H | Louis & Flint, 2017, Environ Microbiol | Reviews how human colonic bacteria form propionate and butyrate via distinct pathways, including acetate-dependent butyrate production requiring cross-feeding partners. | Review | Pathway focus; does not quantify individual SCFA output from consumer tests | scfa, butyrate, propionate, cross-feeding |
| H | Lozupone et al., 2012, Nature | Gut microbial communities vary widely between individuals and over time; alpha diversity (within-sample richness/evenness) must be interpreted with ecological context including diet, age, and disease state. | Review | Pre–shotgun-metagenomics era; conceptual framework more than clinical thresholds | alpha-diversity, ecology, beta-diversity, stability |
| H | Lozupone et al., 2013, Genome Research | Cross-study meta-analysis shows technical variables (16S region, extraction, platform) can bias observed alpha diversity as much as or more than some biological effects. | Meta-analysis | 2013 methods; still relevant for interpreting single-lab consumer scores | alpha-diversity, meta-analysis, methodology, 16s |
| H | Major et al., 2017, Gastroenterology | IBS patients and healthy controls produce similar colonic gas after inulin or fructose challenges; symptom differences reflect colonic hypersensitivity to distension, not excess fermentation alone. | Randomized crossover (MRI + breath hydrogen) | Small cohort; challenge drinks not full dietary patterns | bloating, fodmap, visceral-hypersensitivity, fermentation, ibs |
| H | Marshall et al., 2019, Nutrients | Systematic review estimates roughly 7–15% of post-gastroenteritis patients develop IBS at 3–12 months, with severity and psychological factors influencing risk. | Systematic review | Heterogeneous primary studies and pathogen definitions | pi-ibs, post-infectious, ibs, gastroenteritis |
| H | Massier et al., 2021, Gut | Widely used commercial zonulin ELISAs may not measure prehaptoglobin-2 and correlate poorly with gold-standard permeability tests, undermining many ELISA-based leaky-gut claims. | Review | Focuses on assay validity; does not negate all permeability biology | zonulin, intestinal-barrier, permeability, biomarker |
| H | Moayyedi et al., 2014, Am J Gastroenterol | Meta-analysis of fiber supplementation in IBS found soluble gel-forming fiber (psyllium) beneficial for global symptoms; insoluble wheat bran did not show significant benefit. | Meta-analysis | Heterogeneous trials; fiber types and doses varied | fiber, ibs, psyllium, meta-analysis |
| H | Oliphant & Allen-Vercoe, 2019, Nat Rev Microbiol | Cross-feeding between gut microbes, acetate and lactate donors feeding butyrate and propionate producers, explains why single-taxon interventions often fail to shift SCFA profiles predictably. | Review | Mechanistic review; human dose-response varies by community | cross-feeding, scfa, butyrate, bifidobacterium |
| H | Palleja et al., 2018, Nature Microbiology | In healthy adults, common antibiotics acutely reduce gut microbiome diversity; species richness often returns toward baseline within weeks to months, but compositional and functional differences can persist for at least six months. | Longitudinal intervention | Healthy volunteers, not patients; antibiotic regimens differ from all clinical use | alpha-diversity, antibiotics, recovery, longitudinal |
| H | Pimentel et al., 2014, Gastroenterology | Methane on breath testing associates with constipation-predominant IBS and slower transit; methanogenesis acts as a hydrogen sink altering colonic fermentation. | Review / mechanistic synthesis | Breath-test populations; not all constipation is methane-driven | methane, ibs-c, constipation, breath-testing, methanogens |
| H | Rinninella et al., 2019, Microorganisms | There is no single "healthy" gut microbiome template; diversity and composition vary widely among asymptomatic people by diet, geography, and lifestyle. | Review | Narrative review; does not define consumer-test optimal ranges | alpha-diversity, dysbiosis, healthy-microbiome, interpretation |
| M | Schroeder et al., 2018, Cell Host & Microbe | In mice, low microbiota-accessible carbohydrates erode colonic mucus; dietary fiber or Bifidobacterium supplementation protected mucus thickness. | Intervention | Mouse diet model; human dose and community differ | fiber, mucus, bifidobacterium, intestinal-barrier, mac |
| H | Sokol et al., 2008, PNAS | Faecalibacterium prausnitzii produces anti-inflammatory metabolites and is reduced in some IBD cohorts, an association, not a diagnostic threshold for individuals. | Observational | Cohort associations; abundance varies with diet and sequencing method | faecalibacterium, ibd, inflammation, scfa |
| H | Sonnenburg & Sonnenburg, 2014, Cell Metabolism | Diets low in microbiota-accessible carbohydrates deplete fiber-degrading taxa and reduce fermentation capacity, framing the long-term cost of low-fiber Western diets. | Review | Narrative synthesis; MAC availability is person-specific | fiber, mac, dysbiosis, scfa |
| H | Sperber et al., 2017, Neurogastroenterol Motil (Rome IV overview) | Rome IV defines functional GI disorders by symptom-based criteria and distinguishes them from organic disease when alarm features are absent or adequately investigated. | Guideline | Symptom-based criteria; does not replace endoscopy or serology when indicated | rome-iv, ibs, functional-gut, red-flags |
| H | Spiller & Garsed, 2009, Postgrad Med J | Post-infectious IBS involves persistent motility, immune, and sensory changes after gastroenteritis; many patients improve over 12–24 months without targeted microbiome therapy. | Review | Mechanistic synthesis; treatment trials limited at time of publication | pi-ibs, post-infectious, motility, mechanisms |
| H | Su et al., 2020, Gastroenterology (AGA probiotics guideline) | AGA guidance provides conditional recommendations for specific probiotic strains in selected indications and cautions against indiscriminate use. | Guideline | Conditional recommendations; evidence base evolving | probiotics, guidelines, aga |
| H | Suez et al., 2018, Cell | After antibiotics, autologous fecal microbiota transplant accelerated gut microbiome and mucosal gene expression reconstitution in this trial, whereas a multi-strain probiotic regimen delayed full recovery compared with spontaneous recovery. | RCT | Single trial design; probiotic formulation and timing may not generalize to all products | antibiotics, probiotics, fmt, recovery, post-antibiotic |
| + | Valdes et al., 2018, BMJ | Diet influences gut microbiome composition, but causal effects on long-term health outcomes remain incompletely defined. | Review | Heterogeneous primary studies; association-heavy field | diet, interpretation, evidence-limits |
| H | Villoria et al., 2011, Am J Gastroenterol | Visible abdominal distension in functional gut disorders often reflects abdominophrenic dyssynergia (diaphragmatic descent + abdominal wall relaxation), not necessarily increased intra-abdominal gas volume. | Physiology / imaging cohort | Specialist centre; not all bloating is APD | bloating, distension, abdominophrenic-dyssynergia, motility |
| + | Windey et al., 2012, Molecular Nutrition & Food Research | Colonic protein fermentation yields branched-chain fatty acids, ammonia, and phenolic compounds distinct from saccharolytic SCFA production on fermentable carbohydrate. | Review | Mostly in vitro and animal dose data; human clinical thresholds sparse | protein, bcfas, fermentation, scfa |
One claim per study. Mixed, uncertain, or conflicting findings sit alongside stronger ones; nothing here is ranked or scored.